Table 1:
Overview health technology assessment activities performed.
| country | HTA level 1 outcome Review | HTA level 2 CEA payer perspective | HTA Level 3 CEA society perspective | Conducted by other parties A= association (industry) H= Health economic Institution M=Manufacturer R= Research group | Payer |
|---|---|---|---|---|---|
| Canada | C-Leg | P6 | |||
| Canada | C-Leg | P7 | |||
| USA | MP lower limb prostheses | P5 | |||
| USA | MPK | A, H10 | |||
| USA | Genium | R73 | |||
| Germany | C-Leg | H, M40 | |||
| France | C-Leg | P HAS74 | |||
| France | Kenevo | P HAS75 | |||
| France | Rheo | P HAS81 | |||
| France | Plié | P HAS77 | |||
| Italy | C-Leg | R, M78 | |||
| Italy | MPK | R, M79 | |||
| UK | MPK | P60 | |||
| UK | Orthoses neurologic knee instability | P8 | |||
| Sweden | Kenevo | H, M, R49 | |||
| Sweden | Osteointegration | R80 | |||
| Total publications | 8 | 6 | 2 | 7 | 9 |